Get the Stockscreener App
11.38
0.35%
0.04
After Hours:
11.38
Avid Bioservices Inc stock is traded at $11.38, with a volume of 1.24M.
It is up +0.35% in the last 24 hours and up +7.97% over the past month.
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.
See More
Previous Close:
$11.34
Open:
$11.26
24h Volume:
1.24M
Relative Volume:
1.25
Market Cap:
$720.88M
Revenue:
$139.91M
Net Income/Loss:
$-140.75M
P/E Ratio:
-253.45
EPS:
-0.0449
Net Cash Flow:
$-20.85M
1W Performance:
+2.34%
1M Performance:
+7.97%
6M Performance:
+69.85%
1Y Performance:
+20.55%
1-Day Range:
$11.13
$11.58
1-Week Range:
$10.72
$11.80
52-Week Range:
$4.0705
$12.48
Avid Bioservices Inc Stock (CDMO) Company Profile
Name
Avid Bioservices Inc
Sector
Industry
Phone
714.508.6100
Address
14191 MYFORD ROAD, TUSTIN, CA
Avid Bioservices Inc Stock (CDMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-14-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-08-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Mar-17-21 | Initiated | RBC Capital Mkts | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-10-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Oct-17-19 | Initiated | Stephens | Overweight |
| Oct-16-19 | Initiated | Craig Hallum | Buy |
| Jun-28-19 | Upgrade | Janney | Neutral → Buy |
| May-09-19 | Downgrade | Janney | Buy → Neutral |
View All
Avid Bioservices Inc Stock (CDMO) Latest News
Market Insights: Avid Bioservices Inc (CDMO)’s Notable Gain of 1.52, Closing at 11.34 - The Dwinnex
Investors in cash trouble should check out Avid Bioservices Inc (CDMO) - SETE News
Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Sold by Profund Advisors LLC - MarketBeat
Wall Street SWOT: Avid Bioservices stock rides wave of strong bookings momentum - Investing.com
Avid Bioservices Inc [CDMO] Records 50-Day SMA of $10.49 - Knox Daily
Midday Stock Roundup: Indie Shares Down 5% - Orange County Business Journal
Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Bought by Deerfield Management Company L.P. Series C - Defense World
Avid Bioservices Inc (CDMO) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Deerfield Management Company L.P. Series C Purchases 74,797 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Avid Bioservices (NASDAQ:CDMO) Shares Down 5.1% - Defense World
A better buy-in window may exist right now for Avid Bioservices Inc (CDMO) - SETE News
Rhumbline Advisers Boosts Stake in Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World
American Century Companies Inc. Buys 713,523 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World
Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Sold by AYAL Capital Advisors Ltd - Defense World
AYAL Capital Advisors Ltd Sells 281,338 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Insider Richieri Richard A. sells 530 of Avid Bioservices Inc [CDMO] Stock - Knox Daily
Are Avid Bioservices Inc’shares a good deal? - US Post News
Financial Metrics Check: Avid Bioservices Inc (CDMO)’s Ratios for Trailing Twelve Months - The Dwinnex
Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Sold by 272 Capital LP - Defense World
272 Capital LP Decreases Position in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Astria Therapeutics, Inc. (NASDAQ:ATXS) Shares Sold by Logos Global Management LP - MarketBeat
CVC Management Holdings II Ltd. Buys 902,415 Shares of Advantage Solutions Inc. (NASDAQ:ADV) - MarketBeat
Dimensional Fund Advisors LP Cuts Stake in AeroVironment, Inc. (NASDAQ:AVAV) - Defense World
Interval Partners LP Takes Position in AvidXchange Holdings, Inc. (NASDAQ:AVDX) - MarketBeat
Lombard Odier Asset Management Europe Ltd Makes New $2.30 Million Investment in Avery Dennison Co. (NYSE:AVY) - MarketBeat
(CDMO) Technical Data - Stock Traders Daily
Avidity Biosciences executive sells over $1 million in company stock By Investing.com - Investing.com Canada
Avidity Biosciences executive sells over $578k in stock - Investing.com
Avidity Biosciences CEO sells over $1.4 million in company stock - Investing.com
Avidity Biosciences CFO sells over $500k in company stock - Investing.com
AVAV: AeroVironment Stock Rises on U.S. Army Contract Continuati - GuruFocus.com
Advantage Solutions Inc.’s latest rating changes from various analysts - Knox Daily
Why AeroVironment Shares Are Flying Higher Today - The Motley Fool
AeroVironment (AVAV): U.S. Army has lifted the stop work order - StreetInsider.com
AeroVironment (NASDAQ:AVAV) Shares Gap Up to $182.76 - Defense World
AeroVironment Stock Is Rising Monday: What's Driving The Action? - Benzinga
AeroVironment's stock rises after U.S. Army lifts stop-work order on drone (NASDAQ:AVAV) - Seeking Alpha
Certified Advisory Corp Increases Position in Avantis U.S. Equity ETF (NYSEARCA:AVUS) - Defense World
AeroVironment Says U.S. Army Lifted Stop-Work Order on Contract With Ceiling Value of $990M >AVAV - MarketWatch
Symmetry Investments LP Makes New $265,000 Investment in Avantor, Inc. (NYSE:AVTR) - Defense World
Merriman Wealth Management LLC Sells 358 Shares of Avantis U.S. Equity ETF (NYSEARCA:AVUS) - Defense World
XTX Topco Ltd Invests $889,000 in Avantor, Inc. (NYSE:AVTR) - Defense World
Victory Capital Management Inc. Invests $815,000 in Astera Labs, Inc. (NASDAQ:ALAB) - Defense World
Avidity Biosciences, Inc. (NASDAQ:RNA) Director Arthur A. Levin Sells 5,000 Shares - MarketBeat
Avid Bioservices (NASDAQ:CDMO) Trading 6.3% Higher - Defense World
Victory Capital Management Inc. Increases Stock Position in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
A company insider recently sold 530 shares of Avid Bioservices Inc [CDMO]. Should You Sale? - Knox Daily
Avidity Biosciences director sells shares worth over $228k - Investing.com
E Fund Management Co. Ltd. Cuts Stock Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World
Avid Bioservices Inc (CDMO) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Agilent Completes Acquisition of BIOVECTRA – Company Announcement - Financial Times
Avid Bioservices Inc Stock (CDMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):